日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antibacterial properties of an acrylic resin containing curcumin nanoparticles: An in vitro study

含姜黄素纳米粒子的丙烯酸树脂的抗菌性能:一项体外研究

Khamooshi, Pegah; Pourhajibagher, Maryam; Sodagar, Ahmad; Bahador, Abbas; Ahmadi, Badreddin; Arab, Sepideh

Natural Infection of Phlebotomus sergenti by Leishmania tropica in Libya

利比亚境内白蛉自然感染热带利什曼原虫

Dokhan, Mostafa Ramadhan; Jaouadi, Kaouther; Salem, Sadok; Zenbil, Osama; Gonzalez, Jean Paul; Ben Salah, Afif; Annajar, Badreddin Bashir

A role for versican in the development of leiomyosarcoma

versican 在平滑肌肉瘤发展中的作用

Keire, Paul A; Bressler, Steven L; Lemire, Joan M; Edris, Badreddin; Rubin, Brian P; Rahmani, Maziar; McManus, Bruce M; van de Rijn, Matt; Wight, Thomas N

Inactivation of the RB family prevents thymus involution and promotes thymic function by direct control of Foxn1 expression

RB 家族失活可防止胸腺退化并通过直接控制 Foxn1 表达促进胸腺功能

Phillip M Garfin, Dullei Min, Jerrod L Bryson, Thomas Serwold, Badreddin Edris, Clare C Blackburn, Ellen R Richie, Kenneth I Weinberg, Nancy R Manley, Julien Sage, Patrick Viatour

Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumors

利用KIT特异性单克隆抗体绕过胃肠道间质瘤的伊马替尼耐药性

Edris, Badreddin; Willingham, Stephen; Weiskopf, Kipp; Volkmer, Anne K; Volkmer, Jens-Peter; Mühlenberg, Thomas; Weissman, Irving L; van de Rijn, Matt

Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth

抗KIT单克隆抗体抑制伊马替尼耐药胃肠道间质瘤生长

Badreddin Edris, Stephen B Willingham, Kipp Weiskopf, Anne K Volkmer, Jens-Peter Volkmer, Thomas Mühlenberg, Kelli D Montgomery, Humberto Contreras-Trujillo, Agnieszka Czechowicz, Jonathan A Fletcher, Robert B West, Irving L Weissman, Matt van de Rijn

Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers

对多种已存档的人类癌症样本中的长链非编码RNA和新型转录区域进行转录谱分析

Brunner, Alayne L; Beck, Andrew H; Edris, Badreddin; Sweeney, Robert T; Zhu, Shirley X; Li, Rui; Montgomery, Kelli; Varma, Sushama; Gilks, Thea; Guo, Xiangqian; Foley, Joseph W; Witten, Daniela M; Giacomini, Craig P; Flynn, Ryan A; Pollack, Jonathan R; Tibshirani, Robert; Chang, Howard Y; van de Rijn, Matt; West, Robert B

Flipping the script on macrophages in leiomyosarcoma

颠覆平滑肌肉瘤中巨噬细胞的固有模式

Edris, Badreddin; Weiskopf, Kipp; Weissman, Irving L; van de Rijn, Matt

ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.

ROR2 是一种新型的预后生物标志物,也是平滑肌肉瘤和胃肠道间质瘤的潜在治疗靶点

Edris Badreddin, Espinosa Iñigo, Mühlenberg Thomas, Mikels Amanda, Lee Cheng-Han, Steigen Sonja E, Zhu Shirley, Montgomery Kelli D, Lazar Alexander J F, Lev Dina, Fletcher Jonathan A, Beck Andrew H, West Robert B, Nusse Roel, van de Rijn Matt

Comparative gene expression profiling of benign and malignant lesions reveals candidate therapeutic compounds for leiomyosarcoma

良性和恶性病变的比较基因表达谱揭示了平滑肌肉瘤的候选治疗化合物

Badreddin Edris, Jonathan A Fletcher, Robert B West, Matt van de Rijn, Andrew H Beck